PD-1
|
HGS-S238
|
Mouse |
Recombinant Monoclonal Anti-PD-1 Antibody, Mouse (2F3)
|
|
|
|
|
PD-L1
|
HCB-Y128
|
Mouse |
Monoclonal Anti-PD-L1 Antibody, Mouse IgG1 (1G1)
|
Hybridoma |
|
|
|
PD-L1
|
HCS-S240
|
Rabbit |
Recombinant Monoclonal Anti-PD-L1 Antibody, Rabbit (5D3)
|
|
|
|
|
Rituximab
|
RIB-Y37
|
Mouse |
Anti-Rituximab Antibody (AY37) (recommended for PK/PD)
|
Hybridoma |
|
|
|
Cetuximab
|
CEB-Y29c
|
Mouse |
Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)
|
HEK293 |
|
|
|
Cetuximab
|
CEB-BY31
|
Mouse |
Biotinylated Anti-Cetuximab Antibody (AY31) (recommended for PK/PD)
|
Hybridoma |
|
|
|
Adalimumab
|
ADB-BY17c
|
Mouse |
Biotinylated Anti-Adalimumab Antibody (22E7A4A2) (recommended for PK/PD)
|
HEK293 |
|
|
|
Adalimumab
|
ADB-Y23b
|
Mouse |
Anti-Adalimumab Antibody (AY23b) (recommended for PK/PD)
|
HEK293 |
|
|
|
Bevacizumab
|
BEB-BY13
|
Mouse |
Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)
|
Hybridoma |
|
|
|
Bevacizumab
|
BEB-Y10
|
Mouse |
Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
|
Hybridoma |
|
|
|
Trastuzumab
|
TRB-Y1b
|
Mouse |
Anti-Trastuzumab Antibody (AY1b) (recommended for PK/PD)
|
HEK293 |
|
|
|
Trastuzumab
|
TRB-Y5b
|
Mouse |
Anti-Trastuzumab Antibody (AY5b) (recommended for PK/PD)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M180
|
Human |
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M415
|
Human |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AS113) (Omicron Specific)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M401a
|
Human |
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M402a
|
Human |
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG4 (AM359b) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M400a
|
Human |
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG2 (AM359b) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M265
|
Human |
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M370
|
Human |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM110) (Delta Specific)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M58P1
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-Y170
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific)
|
Hybridoma |
|
|
|
Spike RBD
|
SPD-Y171
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5F8E1) (XBB.1.5/Omicron Specific)
|
Hybridoma |
|
|
|
Spike RBD
|
SPD-M416
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS106) (Beta & Gamma Specific)
|
Hybridoma |
|
|
|
Spike RBD
|
SPD-S298
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-S299
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-Y168
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific)
|
Hybridoma |
|
|
|
Spike RBD
|
SPD-BM227
|
Mouse |
Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (MALS verified)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M196b
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA2 (AM130)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-PM226
|
Mouse |
PE-Labeled Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122)
|
HEK293 |
|
|
|
Spike RBD
|
SPD-M334
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AM334) (Beta & Gamma Specific) (MALS verified)
|
HEK293 |
|
|
|